MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus

MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus

Abstract Background Non-small cell lung cancer (NSCLC) is a deadly human malignancy, and previous studies support the contribution of microRNAs (miRNAs) to cancer assessment. It has been reported that miR-1231 can be used as a biomarker to assess prognosis in different cancers. However, the prognost...

Full description

Bibliographic Details
Main Authors: Jing Li, Jialiang Xu, Zhijun Cao, Shouzuo Du, Luyu Zhang
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Cancer Cell International
Subjects:
Non-small cell lung cancer
Diabetes mellitus
miR-1231
Overall survival
The prediction model
Online Access:http://link.springer.com/article/10.1186/s12935-020-01525-z

Internet

http://link.springer.com/article/10.1186/s12935-020-01525-z

Similar Items